Tag: Covaxin

The DCGI approval came after the SEC on COVID-19 of the CDSCO on January 19 recommended granting regular market approval to the SII's Covishield and Bharat Biotech's Covaxin for use in adult population subject to certain conditions.

Dr Krishna Ella and Suchitra Ella, the couple behind Bharat Biotech, which developed India's first indigenous vaccine for Covid-19, have been awarded Padma Bhushan, the third highest civilian award in the country.

Hyderabad-based Bharat Biotech had submitted complete information on chemistry, manufacturing, and controls, along with the pre-clinical and clinical data while seeking regular market authorisation for Covaxin.

The cumulative COVID-19 vaccine doses administered in the country have reached 158.74 crore so far, the Union Health Ministry said on Tuesday.

Citing the study results, Bharat Biotech noted that more than 90 per cent of all individuals boosted with Covaxin showed neutralising antibodies.

COVAXIN Booster Dose Data Shows Promising Results

As per the findings, Indicative studies have shown that 3 doses of Wuhan-strain based vaccines may provide only partial protection from infection with this variant

Adding another feather in the cap of India’s vaccination drive, the much-awaited inoculation of teenagers in the 15-18 years age group kicked off across the country on Monday (January 3). About 42 lakh children in the age group were inoculated on the first day of Covid vaccination.

The vaccine used for inoculating children is Bharat Biotech's Covaxin, according to a set of new guidelines issued by the Union health ministry.

No serious adverse event was reported. 374 subjects reported either mild or moderate severity symptoms with 78.6 per cent getting resolved within one day.

According to new guidelines issued by the Union health ministry on Monday, the vaccine option against COVID-19 for children in the age group of 15-18 years, who will be inoculated from January 3, would be Covaxin only

On the ongoing RDA strike which has hit all the medical services in the national capital, the IMA said that the issue of expediting PG counselling is the need of the hour to increase manpower ahead of the looming third wave threat.

The DCGI gave its approval Friday, the source said.

The research was conducted during the peak of India's second wave of COVID-19 with high test positivity rates for both hospital employees and residents of Delhi, they said.

An MoU was signed to recognise Covid-19 vaccine certification by India's Ambassador to Nepal Vinay Mohan Kwatra and the Himalayan nation's Health Secretary on Tuesday.